Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study.
about
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@en
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@nl
type
label
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@en
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@nl
prefLabel
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@en
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@nl
P2093
P2860
P1476
Trabectedin plus pegylated lip ...... ervational, multicenter study.
@en
P2093
Dietmar Reichert
Ingo B Runnebaum
Jalid Sehouli
Markus Kuther
Pauline Wimberger
Tobias Hesse
Uta Ringsdorf
P2860
P2888
P304
P356
10.1007/S00432-018-2637-1
P577
2018-04-06T00:00:00Z